EFNS guidelines on cognitive rehabilitation: report of an EFNS task force.

Disorders of language, spatial perception, attention, memory, calculation and praxis are a frequent consequence of acquired brain damage [in particular, stroke and traumatic brain injury (TBI)] and a major determinant of disability. The rehabilitation of aphasia and, more recently, of other cognitive disorders is an important area of neurological rehabilitation. We report here a review of the available evidence about effectiveness of cognitive rehabilitation. Given the limited number and generally low quality of randomized clinical trials (RCTs) in this area of therapeutic intervention, the Task Force considered, besides the available Cochrane reviews, evidence of lower classes which was critically analysed until a consensus was reached. In particular, we considered evidence from small group or single cases studies including an appropriate statistical evaluation of effect sizes. The general conclusion is that there is evidence to award a grade A, B or C recommendation to some forms of cognitive rehabilitation in patients with neuropsychological deficits in the post-acute stage after a focal brain lesion (stroke, TBI). These include aphasia therapy, rehabilitation of unilateral spatial neglect (ULN), attentional training in the post-acute stage after TBI, the use of electronic memory aids in memory disorders, and the treatment of apraxia with compensatory strategies. There is clearly a need for adequately designed studies in this area, which should take into account specific problems such as patient heterogeneity and treatment standardization.

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

Cardiovascular disease (CVD) due to atherosclerosis of the arterial vessel wall and to thrombosis is the foremost cause of premature mortality and of disability-adjusted life years (DALYs) in Europe, and is also increasingly common in developing countries.1 In the European Union, the economic cost of CVD represents annually E192 billion1 in direct and indirect healthcare costs. The main clinical entities are coronary artery disease (CAD), ischaemic stroke, and peripheral arterial disease (PAD). The causes of these CVDs are multifactorial. Some of these factors relate to lifestyles, such as tobacco smoking, lack of physical activity, and dietary habits, and are thus modifiable. Other risk factors are also modifiable, such as elevated blood pressure, type 2 diabetes, and dyslipidaemias, or non-modifiable, such as age and male gender. These guidelines deal with the management of dyslipidaemias as an essential and integral part of CVD prevention. Prevention and treatment of dyslipidaemias should always be considered within the broader framework of CVD prevention, which is addressed in guidelines of the Joint European Societies’ Task forces on CVD prevention in clinical practice.2 – 5 The latest version of these guidelines was published in 20075; an update will become available in 2012. These Joint ESC/European Atherosclerosis Society (EAS) guidelines on the management of dyslipidaemias are complementary to the guidelines on CVD prevention in clinical practice and address not only physicians [e.g. general practitioners (GPs) and cardiologists] interested in CVD prevention, but also specialists from lipid clinics or metabolic units who are dealing with dyslipidaemias that are more difficult to classify and treat.

Certificate of need, state health planning, and the state bonding authority for health facilities construction and development : Task Force report to the Council.

Cover title.

Cost shifting, hospital financial viability, and accessibility of hospital care : Task Force report to the Council.

Cover title.

Database evaluation, quality of care, and utilization review : Task Force report to the Council.

Cover title.

Economic impact study of the proposed motor vehicle (in-use) noise regulations : report of the Task Force on noise.

Bibliography: p. 152-155.

Governor's Earthquake Preparedness Task Force report.

"April 2, 1990."

Governor's Small Business Environmental Task Force report & recommendations.

"April 1994."

Governor's Task Force on Occupant Protection : final report.

Running title: Task force final report.

Governor's Task Force on Day Care : final report.

"August 1987."

Governor's Task Force on Detention Standards report, 1987.

Fred L. Foreman, Chairman.

Health Care Worker Task Force : interim report, December 31, 1996 /

Caption title.

Health Care Worker Task Force as directed by Senate Resolution 206.

Final report of the Task Force which was directed by Illinois Senate Resolution 206 to make recommendations with respect to the best methods to implement a criminal background check of EMT's.

Governor's Task Force on Low-Income Energy Issues : final report.

"Staffed by: Department of Energy and Natural Resources, Department of Commerce and Community Affairs, [and] Illinois Commerce Commission."

Industrial Hemp Investigative and Advisory Task Force report /

The Industrial Hemp Investigative and Advisory Task Force was created to study the economic viability of industrial hemp production in Illinois, to identify any legal or other obstacles to industrial hemp production, and to make recommendations.